Drugs / PRAX-222
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05737784 | Apr 2023 → Aug 2025 overdue | genetic developmental and epileptic encephalopathy | Praxis Precision Medicines | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRAX-222 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05737784 ↗ |